Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Biopharma Cred. (BPCR) Share Price

Price $0.87 on 01-08-2025 at 18:50:05
Change $0.002 0.23%
Buy $0.872
Sell $0.866
Last Trade: Sell 72.00 at $0.87
Day's Volume: 601,084
Last Close: $0.87
Open: $0.866
ISIN: GB00BDGKMY29
Day's Range $0.86 - $0.87
52wk Range: $0.80 - $0.94
Market Capitalisation: $982.52m
VWAP: $0.866132
Shares in Issue: 1.13b

Biopharma Cred. (BPCR) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 72 $0.87 Automatic Execution
16:36:12 - 01-Aug-25
Sell* 3,203 $0.87 Uncrossing Trade
16:35:18 - 01-Aug-25
Sell* 1,490 $0.86869 Ordinary
16:27:43 - 01-Aug-25
Sell* 12,960 $0.866 Automatic Execution
16:23:46 - 01-Aug-25
Sell* 1,383 $0.862 Automatic Execution
15:38:09 - 01-Aug-25
Sell* 2,494 $0.862 Automatic Execution
15:37:56 - 01-Aug-25
Unknown* 3,058 $0.858611 Ordinary
Currency Conversion
15:20:32 - 01-Aug-25
Unknown* 75,278 $0.862 Ordinary
15:17:56 - 01-Aug-25
Unknown* 19 $0.863495 Currency Conversion
Negotiated Trade
15:17:02 - 01-Aug-25
Buy* 16 $0.864 SI Trade
15:14:01 - 01-Aug-25
See more Biopharma Cred. trades

Biopharma Cred. (BPCR) Share Price History

Time period:
to
Date Open High Low Close Volume
1st Aug 2025 (Fri) 0.866 0.87 0.86 0.87 601,084
31st Jul 2025 (Thu) 0.878 0.878 0.866 0.868 1,311,589
30th Jul 2025 (Wed) 0.876 0.878 0.864 0.874 907,111
29th Jul 2025 (Tue) 0.874 0.876 0.87 0.87 1,590,399
28th Jul 2025 (Mon) 0.88 0.88 0.874 0.874 447,513
25th Jul 2025 (Fri) 0.874 0.878 0.87 0.87 1,478,748
24th Jul 2025 (Thu) 0.876 0.876 0.87 0.874 1,868,781
23rd Jul 2025 (Wed) 0.876 0.878 0.876 0.876 447,663
22nd Jul 2025 (Tue) 0.88 0.88 0.876 0.878 683,035
21st Jul 2025 (Mon) 0.884 0.884 0.876 0.88 850,160
18th Jul 2025 (Fri) 0.884 0.884 0.882 0.882 705,076
17th Jul 2025 (Thu) 0.88 0.886 0.88 0.882 298,185
16th Jul 2025 (Wed) 0.884 0.884 0.878 0.882 307,501
15th Jul 2025 (Tue) 0.866 0.886 0.866 0.88 430,650
14th Jul 2025 (Mon) 0.882 0.882 0.876 0.88 1,649,664
11th Jul 2025 (Fri) 0.88 0.886 0.862 0.874 1,890,278
10th Jul 2025 (Thu) 0.874 0.882 0.872 0.88 1,638,579
9th Jul 2025 (Wed) 0.878 0.882 0.876 0.88 715,328
8th Jul 2025 (Tue) 0.88 0.884 0.878 0.88 391,605
7th Jul 2025 (Mon) 0.886 0.888 0.876 0.88 704,814
4th Jul 2025 (Fri) 0.886 0.886 0.88 0.88 257,230
3rd Jul 2025 (Thu) 0.888 0.888 0.878 0.878 768,100
2nd Jul 2025 (Wed) 0.884 0.888 0.88 0.88 953,696
See more Biopharma Cred. price history

Biopharma Cred. (BPCR) Regulatory News

Date Source Headline
31st Jul 2025 7:00 am RNS Appointment of New Director
21st Jul 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
18th Jul 2025 4:23 pm RNS Holding(s) in Company
1st Jul 2025 12:02 pm RNS STATEMENT RE BIOCRYST
24th Jun 2025 3:39 pm RNS Holding(s) in Company
20th Jun 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
18th Jun 2025 7:00 am RNS Dividend Declaration
10th Jun 2025 10:56 am RNS Director Declaration
9th Jun 2025 4:37 pm RNS Result of AGM
22nd May 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
See more Biopharma Cred. regulatory news

Biopharma Cred. (BPCR) Share News

UK dividends calendar - next 7 days

24th Jul 2025 13:48

Read More

IN BRIEF: BioPharma Credit to be repaid following disposal by BioCryst

1st Jul 2025 14:20

BioPharma Credit PLC - London-based closed-ended investment company focused on the life sciences industry - Investment Manager Pharmakon Advisors LP notes that BioCryst Pharmaceuticals Inc has agreed to sell its European Orladeyo, or berotralsat, business to Neopharmed Gentili for up to USD264 million. Orladeyo is a treatment to prevent attacks of hereditary angioedema in adults and children 12 years of age and older. BioCryst expects to complete the disposal by early October, and intends to use the proceeds to repay its remaining USD248.7 million term debt. This includes the repayment of USD99.5 million owed to BioPharma. Under the terms of its senior secured loan deal with BioCryst, which was initially agreed in April 2023, BioPharma expects to receive a prepayment premium of 3% to the principal repaid. Read More

IN BRIEF: BioPharma Credit declares unchanged quarterly dividend

18th Jun 2025 12:44

BioPharma Credit PLC - London-based closed-ended investment company focused on the life sciences industry - Declares interim dividend of 1.75 US cents for the second quarter to the end of June, unchanged from the prior year. The dividend will be paid on July 31. Says it continues to target a base annual dividend of 7 cents per share. It paid a total dividend of 10.18 cents for 2024. Read More

UK shareholder meetings calendar - next 7 days

2nd Jun 2025 12:36

Read More

UK dividends calendar - next 7 days

30th Apr 2025 14:18

Read More

See more Biopharma Cred. news
FTSE 100 Latest
Value9,068.58
Change-64.23

Login to your account

Forgot Password?

Not Registered